Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Histone deacetylase inhibitors (HDIs) are a group of potent epigenetic drugs which have been investigated for their therapeutic potential in various clinical disorders, including hematological malignancies and solid tumors. Currently, several HDIs are already in clinical use and many more are on cli...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Wawruszak, Anna, Kalafut, Joanna, Okon, Estera, Czapinski, Jakub, Halasa, Marta, Przybyszewska, Alicja, Miziak, Paulina, Okla, Karolina, Rivero-Muller, Adolfo, Stepulak, Andrzej
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2019
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6406474/
https://ncbi.nlm.nih.gov/pubmed/30691229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11020148
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker